poisar

Stock

Savara Inc. SVRA

$5.62+0.36%

Overview

SVRA market data

Price History

SVRA price chart · 1M
O
5.59
H
5.68
L
5.52
C
5.62
Vol
101,097.00
Source
US equities market feed
Observed
Aug 26, 2026, 12:00 AM
Cadence
Five-minute page cache; daily and stored hourly bars
Status
fresh

Key Stats & Performance

Open
$5.59
Previous Close
$5.60
Day High
$5.68
Day Low
$5.52
52 Week High
$6.48
52 Week Low
$4.70
7 Day Return
+0.36%
30 Day Return
+3.50%
90 Day Return
+10.20%
1 Year Return
+6.54%
Daily Notional Volume
$568.2K
Latest daily bar volume multiplied by its closing price.

Valuation & Profitability

Provider-backed
P/E (TTM)
Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
Forward P/E
P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
EPS (TTM)
-$0.48
Diluted earnings per share over the trailing twelve months.
Beta
0.19
Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
Dividend Yield
Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
Profit Margin
-4,253.9%
Net income divided by revenue. Comparable within a sector, less so across sectors.
52w range
$3.08 – $7.01
Lowest and highest closing prices over the past 52 weeks.
Analyst Target
Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.

Display-only. Refreshed once per symbol per 24 hours · market cap $1.1B · P/B 6.04 · P/S 4,168.47.

Company News

7 captured
Savara Announces Acceptance Of Oral Presentation, Two Poster Presentations From Phase 3 IMPALA-2 Clinical Studies At ERS CongressBenzinga · Aug 24, 2026, 8:08 PM
Savara Says MOLBREEVI MAAs Under Review By EMA And U.K's MHRA; Decisions Expected Q1 2027 And Q4 2026, Respectively; European And Australian Patent Offices Grant MOLBREEVI Patents Until March 2041Benzinga · Aug 11, 2026, 9:01 PM
Savara Q2 EPS $(0.16) Misses $(0.14) EstimateBenzinga · Aug 11, 2026, 8:37 PM
Savara Announces European And Australian Patents Granted Covering MOLBREEVI Liquid Formulation, Securing Protection Through March 2041Benzinga · Jul 30, 2026, 12:11 PM
Savara Announces Chief Financial and Administrative Officer TransitionBenzinga · Jun 8, 2026, 9:15 PM
8-K filing — Savara Inc (SVRA)SEC EDGAR · Jun 8, 2026, 8:15 PM
Savara Chief Financial And Administrative Officer Dave Lowrance Stepping Down, Effective July 15; COO Robert Lutz To Assume Additional Role Of CFOBenzinga · Jun 8, 2026, 8:15 PM

Decision & Score

Members

Our Tradable / Watch / Avoid decision and 0–100 conviction score for this symbol are members-only.

Create account to unlock

Trend & Pattern Evidence

Members

Trend alignment and backtested chart-pattern probabilities are members-only.

Create account to unlock

Sector Peer Ranking

Members

Ranked sector peers with scores and decisions are members-only.

Create account to unlock